¿Es Hora de Abandonar el Índice de Masa Corporal (IMC)? by Bergonzoli, Gustavo
1 iJEPH. 2018, 1(1): e-007. doi: 10.18041/2665-427X/ijeph.1.3877
Original Research
1 Epidemiologist, Knowledge Production and 
Management Foundation. Cali, Colombia.
2 Coordinador área de Investigación – ESE 
Hospital Tomas Uribe Uribe, Tulua, Colombia
Correspondence to: Gustavo Bergonzoli. 
Carrera 120 # 15 – 123 Casa 30. Cali, 
Colombia. E-mail: fundaprogesco@gmail.
com.
Received: July 15, 2018
Accepted: September 27, 2018 
Keywords: BMI, Accuracy, Validity, 
Skewness, Maximum likelihood ratio, ROC.
Palabras clave: IMC, Exactitud, Validez, 
Tasa de Probabilidad Máxima, Distribución 
anormal
Cite this as: Bergonzoli G. Is it time to leave 
the Body Mass Index (BMI)? IJEPH. 2018; 
1(1): e007.  Doi: Doi: 10.18041/2665-
427X/ijeph.1.3877.
Resumen
Introducción: El estudio fue realizado con la finalidad de 
estimar la exactitud en la medición del estado nutricional 
de las personas utilizando la nueva fórmula del Índice 
de Masa Corporal (IMC), teniendo como parámetro de 
comparación el IMC tradicional. 
Métodos: El análisis de exactitud fue realizado mediante 
la estimación de la sensibilidad, especificidad, valor 
predictivo positivo y negativo, los índices de Youden y 
Kappa, además de la razón de máxima verosimilitud y la 
curva ROC. 
Resultados: Aunque la nueva fórmula IMC arrojó 
resultados similares a la fórmula tradicional en la mayoría 
de los indicadores examinados. Ambas fórmulas presentan 
una distribución muy sesgada a la derecha, siendo mayor 
en la nueva fórmula comparada con la tradicional. Los 
resultados fueron mayores en la nueva fórmula, siendo 
5.91 y 4.81 en el grupo de sobrepeso, y 30.9 and 30.3, en 
el grupo obeso. 
Conclusión: Si bien los resultados encontrados apuntan 
a que la nueva fórmula se comporta de forma similar a 
la fórmula original y, por tanto, podrían ser utilizadas en 
forma intercambiable. Los hallazgos señalan que ambas 
fórmulas presentan una amplia dispersión hacia la derecha, 
sesgo que afecta la validez en la medición del sobrepeso y 
obesidad, resultado que no permite ser recomendadas.
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Abstract
Background: This study was conducted to assess the 
accuracy when calculating the nutritional status using 
the new Body Mass Index formula (BMI), taking as Gold 
Standard the traditional BMI. 
Methods: The diagnostic accuracy compared the new BMI 
formula to the traditional BMI. Accuracy analysis included 
sensitivity, specificity, and predictive values (positive and 
negative), Youden index, Kappa index, ROC, and maximum 
likelihood ratio. 
Results: The new BMI formula yielded good results for all 
indicators used for measuring the accuracy, in all groups. 
These results are a good evidence that the new BMI formula 
could replace the traditional BMI for screening population 
based nutritional status. However, the new BMI formula 
detected less subjects in subnormal, normal, and overweight 
groups; and, more in the obese group. The distribution is 
biased to the right in both formulas. In overweight and 
obese groups, the skewness is bigger in the new formula 
than the original formula; being the skewness 5.91 and 4.81; 
and 30.9 and 30.3, respectively. 
Conclusion: Although the results are good evidence that 
new BMI formula yields similar results to the BMI formula 
for screening nutritional status at population level, and 
therefore, could be used interchangeably. Both formulas 
lack some validity in measuring the obese nutritional 
status, which do not allow recommending either of these 
formulas, due to the large dispersion of both formulas.
Key Study Facts
Objective To assess the accuracy when calculating the nutritional status using the new Body Mass 
Index formula (BMI), taking as Gold Standard the traditional BMI. 
Study design Cross-sectional
Source of data Data base from the study developed by the research group CEDETES, of the University 
of Valle in Cali, Colombia, oriented to measurement risk factors for non-communicable 
diseases in the municipality of Santiago de Cali in 2013
Population/Sample 6,965 adult records of BMI
Statistical analysis Accuracy analysis included sensitivity, specificity, and predictive values (positive and 
negative), Youden index, Kappa index, ROC, and maximum likelihood ratio
Main finding The new BMI formula yielded good results for all indicators used for measuring the ac-
curacy, in all groups. These results are a good evidence that the new BMI formula could 
replace the traditional BMI for screening population based nutritional status. However, 
the new BMI formula detected less subjects in subnormal, normal, and overweight 
groups; and, more in the obese group.
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Introduction
When, in 1832, the Belgian mathematician, Adolphe Quetelet 
proposed an instrument to select the fittest men to enter the 
Belgian imperial army based on his very own principle, according 
to which: “the transverse growth of a man is less than the 
vertical,” the intention was not to measure obesity, but to find 
the men with the physical characteristics most apt to defend the 
interests of the Belgian empire in the African continent (1).
Shortly before the First World War, actuaries began to notice the 
links between obesity and life insurance claims, and it was then 
when the Quetelet Index became a useful tool for estimating life 
insurance premiums. Later, in 1972, Ancel Keys, an American 
scientist who studied the effect of diet on health, rescued the 
index. Then, in 1980, JS Garrow and JD Webster introduced the 
categories recognized as “obesity” and “overweight” (2,3). 
Since 1980, obesity has more than doubled worldwide, and in 
2014, more than 1,900 million adults (39%) aged 18 or over were 
overweight, of which 13% more than 600 million were obese. In 
that same year, 41 million children under the age of five were 
overweight or obese, and at least 2.8 million people die each 
year from overweight or obesity. Economic analysis suggests that 
each 10% increase in NCDs is associated with a 0.5% decrease in 
the annual growth of the economy (4).
The 2013 Global Burden of Disease Study, published in May 
2014, showed that 37% of men and 38% of women had a body-
mass index of 25 kg/m2 or greater, a rise of 28% in adults and of 
47% in children since 1980. An estimated 2.1 billion people are 
overweight globally. In addition, while some developed countries 
have seen an apparent slowing of the rise in obesity prevalence 
since 2006, no country has reported significant decreases for 
three decades (5).
The World Health Organization (WHO) declared, in 2011, that 
obesity and overweight derived from the increase in dietary 
energy consumption had reached epidemic levels. Obesity and 
overweight are defined as an abnormal or excessive accumulation 
of fat that can be detrimental to health and are considered 
precursor conditions for the development of non-communicable 
diseases, including diabetes, cardiovascular diseases, and cancer 
(6).
In the United States, in 2008, it was estimated that health costs 
derived from obesity care amounted to 147 billion dollars; 
indeed, practically 10% of all medical expenses for that year. The 
aforementioned figure is much higher than 78,500 million dollars 
the cost estimated in 1998. This increase in cost can be attributed 
to the increased prevalence of overweight and obesity (7). 
In the United Kingdom, a variation in health expenditure 
attributable to obesity has been calculated to be between 2.3 and 
4.6% of total health expenditure (8). In Canada, a study on the 
economic cost of 8 diseases associated with obesity estimated 
the cost at 2 billion Canadian dollars, while another study on the 
impact of 18 diseases associated with overweight and obesity 
estimated 6,000 million Canadian dollars (9). 
Many health economists are interested in estimating the social 
costs attributable to overweight and besity, taking into account 
factors such as early retirement, work efficiency, and the prospects 
of a healthy life. It is estimated that social costs represent 60% of 
the total cost of being overweight or obese (10).
In 2014, the McKinsey Institute estimated that the economic 
burden of being overweight or obese was 2 billion dollars, 
equaling the expense of smoking and all armed conflicts (11).
Therefore, considering the measurement of overweight and 
obesity is very important for making informed decisions because 
of the great impact on health and the economy.
The Body Mass Index (BMI) continues to be the dominant 
instrument that produces the data, by which the declaration of 
obesity as a global epidemic is based, and this fact would not 
be very important if it were not associated with the need to 
intervene in persons classified as obese or overweight, given the 
BMI’s established relationship with a wide variety of diseases, and 
the resources required for their care, which for many countries 
represents a great fiscal effort.
During the last two decades, some scientists have questioned 
the validity of this instrument to measure the ideal weight of 
a person to the point that Nick Trefethen (12), a professor of 
mathematics, said that the body mass index, the standard tool to 
measure the rate of overweight and obesity, was flawed because 
it does not take into account the fact that taller people could 
carry extra natural weight without being obese. He introduced a 
new formula and insisted that his formula, far from being simply 
an academic exercise, was an urgent necessity since the results 
could affect millions of people. The purpose of this study was 
to measure how accurate the new formula is in measuring the 
nutritional status of people, compared with the traditional BMI 
formula. 
What is known
The BMI has been used for classifying nutritional status at 
population level. World Health Organization (WHO) has 
supported the use of this instrument. Concerns about BMI 
validity have arisen lately, due to some detected flaws on the 
traditional formula. 
What is new
New formula has been proposed to replace the traditional one. 
However, the accuracy of the new formula has not been tested. 
This study result contributes with a new piece of knowledge 
showing that the new formula behave as good as the traditional 
one, but both have shortcomings when measuring obese people, 
finding that makes it difficult to recommend them.
Methods
The present investigation is located within the framework of 
cross-sectional observational studies, due to the modality of data 
collection that is subject to a fixed and instantaneous temporality. 
The source of the data was a base product of the study developed 
by the research group CEDETES, of the University of Valle in 
Cali, Colombia, oriented to measurement risk factors for non-
3 iJEPH. 2018, 1(1): e-007. doi: 10.18041/2665-427X/ijeph.1.3877
communicable diseases in the municipality of Santiago de Cali in 
2013. 
For the data collection, a stratified multistage sampling 
(neighborhoods, blocks, homes) with probability of inclusion of 
the primary units proportional to the size of the study domain 
(commune) was designed. The primary sampling unit (first stage) 
was the neighborhoods, the second the blocks of each stratum, 
and the tertiary units (third stage) the dwellings occupied by the 
households of the selected blocks. The sampling terminal unit 
always corresponds to the observation unit that for this study 
were the people that make up the family inside the household.
The first stage of the sampling involved the random selection of 
1,200 blocks (1,000 principal and 200 replacement if required) 
distributed in the different neighborhoods of each commune. 
In the second stage, 4 households were selected from each block 
by systematic sampling with random start; so that, there is a total 
of 4,000 surveys conducted, that are distributed in the 1,000 
selected blocks of the 22 communes of the urban area of the 
municipality of Santiago from Cali Colombia.
A cleaning process to the database provided was carried out 
prior to the statistical analysis in order to correct errors and 
discard records that were outside the expected range. The 
data dictionary, manuals, and protocols for the handling of 
inconsistencies and missing data were reviewed.
All the records of people over 18 years of age on which there was 
a registry of weight and height were used. We excluded people 
with height less than or equal to 1.40 m and weight less than or 
equal to 40 kg, regardless their age.
It was verified, by means of certain statistical procedures, the 
detection of violations to statistical assumptions that could 
cause certain errors or unrealistic results, which would lead to 
conclusions far from the accumulated body of knowledge. 
The statistical analysis for the estimation of the accuracy in the 
measurement of the nutritional status of the two formulas was 
made by having as a comparison parameter or “Gold standard” 
the results obtained from the application of the traditional 
formula or BMI, which divides the weight in kilograms by the size 
in meters squared. These measurements were compared with 
the results obtained from the application of the new formula, 
which consists of the ratio between the product of the weight in 
kilograms, multiplied by the constant 1.3, divided by the height in 
meters, raised to the power 2.5. 
Accuracy analysis included sensitivity, specificity, and predictive 
values (positive and negative) and was expressed as follows: 100-
85% ‘very good’; 84-70% ‘good’; 69-55% moderate and ≥55% 
‘weak’. Two indexes for interpreting the accuracy of the new BMI 
formula and the current BMI formula as a gold standard were: 
You index, which reflects the difference between the rate of 
true positives and false positives; and the Cohens’ Kappa test, a 
measure of agreement between two raters occurring by chance 
.The concordance strength for Youden and Kappa values was 
expressed as follows: 0.81-1.00 “very good”, 0.61-0.80 “good”; 
0.41-0.60 moderate; and ≤ 0.40 “weak”. The receiver operation 
curve (ROC) was also estimated to compare the probability area 
under the new BMI curves, as the area under the curve reflects 
the proportion of individuals correctly classified, regardless of 
the cut-off chosen or the decision rule. The ROC curve has an 
advantage over the other measures used because it integrates 
sensitivity and specificity into a single measure. Likelihood ratios 
are an alternative for assessing the performance of a diagnostic 
instrument. The likelihood ratio for a particular value of a 
diagnostic test is defined as the probability of the test result in 
people with the attribute divided by the probability of the result 
in people without the attribute. This probability indicates how 
many times more (or less) likely a test result is to be found in 
people with the attribute compared with people without it. The 
main advantage of likelihood ratios is that they go beyond the 
simple and vague classification of a test result as either normal or 
abnormal. Finally, the accuracy test measures the ratio between 
the proportion of true positives and true negatives; it is measured 
based on its ability to differentiate the subjects with the attribute 
(13-15).
These indicators were estimated in each of the 4 categories 
established by the World Health Organization as a reference for 
the classification of the nutritional status of people, as follows: 
subnormal weight, those individuals whose BMI is less than 18.5; 
normal weight for those between 18.5 and 24.9; overweight 
for those between 25.0 and 29.9, and obesity for those with a 
BMI equal to or greater than 30.0. The statistical analysis was 
done using IBM SPSS® Statistics software, version 24.0, and SAS® 
Statistics software, version 9.4.
Results
The new formula detected 21 (10.8%) subjects less in the 
subnormal weight category, 195 (6.8%) less in the normal weight 
category, 22 (0.84%) less in the overweight category, and 263 
(18.3%) more among the obese (Table 1).
The distribution of both formulas in the subnormal and normal 
groups is skewed to the left while in the overweight and obesity 
groups they are to the right (Table 2). The bias in the traditional 
formula is greater where a greater number of extreme values is 
Nutritional status formula Subnormal Normal Overweight Obese Total
BMI 194 2,871 2,613 1,287 6,965
New BMI 173 2,676 2,591 1,523 6,963
Table 1. Nutritional Status Distribution Based on Both Formulas. 
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observed, compared with the new formula.
In the groups of subnormal weight, for BMI and New BMI (Figure 
1), the result of the Normality test, Kolmogorov-Smirnov (KS) 
= 0.106, df = 194, p = 0.000; KS = 0.125, df = 173, p = 0.000; 
respectively. In the normal weight groups, the Normality test, 
Kolmogorov-Smirnov (KS) = 0.083, df = 2871, p = 0.000; KS = 
0.096, df = 2.676, p = 0.000; respectively. In both groups and 
formulas, the distribution is skewed to the left.
In the overweight groups, for BMI and New BMI (Figure 2), the 
result of the Normality test, Kolmogorov-Smirnov = 0.071, df = 
2613, p = 0.000; KS = 0.081, df = 2591, p = 0.000; respectively. In 
the obese groups, the Normality test, Kolmogorov-Smirnov (KS) 
= 0.153, df = 1281, p = 0.000; KS = 0.143, df = 1517, p = 0.000; 
respectively. In both groups and formulas, the distribution is 
biased to the right. The traditional formula is much more biased 
in the overweight group, the skewness was 5.91 and 4.81; and 
so, it is in the obese group, skewness 30.9 and 30.3, respectively.
The performance of the indicators obtained from the new formula 
is good, and except for the sensitivity, all the other results can be 
defined as very good, according to the established criteria (Table 
3).
Discussion
Accuracy and agreement become important when one wants to 
know if a new method or an instrument result is equivalent to 
the original; so that, eventually, they can be exchanged either 
because one of them is simpler, less expensive, and therefore, 
more cost/effective, or because it is safer for clinical practice or 
public health screening.
The results of this study show that except for sensitivity the 
other indicators perform very well, making the two instruments 
comparable and interchangeable. However, the detection of 
subjects in the subnormal, normal, and overweight groups is 
lower in the new formula while it is higher in the obese group; 
This situation would have important implications for public health 
since the new formula tends to classify more subjects as obese.
It should be noted, that the distribution of the subjects within 
each group and for both formulas does not follow a normal 
distribution. A greater number of extreme values are observed in 
the obese group using both formulas, making us think that these 
two formulas are not accuracy in this specific nutitional status. 
Although the validity of the traditional formula is highly 
questioned, and the results obtained with the new formula 
are similar to those obtained with the traditional formula and 
therefore, could be interchangeable, the asymmetry to the right 
observed in both formulas suggests, that none of these formulas 
is suitable for measuring the obese status, due to their great 
asymmetry towards the right.
Additionally, studies differ in their assessment of the relationship 
between BMI and mortality. In particular, BMI in the overweight 
category (BMI 25- <30 kg/m2) is not consistently associated 
with increased mortality (18, 19). This situation that has led to a 
Nutritional status Subnormal Normal Overweight Obese
Statistical BMI New BMI BMI New BMI BMI New BMI BMI New BMI
N 194 173 2,871 2,676 2,613 2,591 1,287 1,523
Mean 17.26 17.27 22.50 22.62 27.10 27.17 33.52 34.00
St Dev 0.8779 0.8675 1.6793 1.6772 1.3960 1.3657 3.9628 4.2040
Skewness -3.26 -4.52 -3.23 -5.51 5.90 4.81 52.41 49.67
Table 2. Descriptive Statistics for both Formulas and Groups.
Figure 1.  Both formulas Subnormal and Normal Groups distri-
bution.
Figure 2. Both formulas Overweight and Obese Groups 
distribution. 
5 iJEPH. 2018, 1(1): e-007. doi: 10.18041/2665-427X/ijeph.1.3877
debate about the validity of BMI and its established cut-off points 
for the classification of the nutritional status of people.
One of the limitations of this study is that it does not examine 
the validity of both formulas, because there is a lot of discussion 
regarding what BMIs try to measure since they do not take into 
account muscle mass, bone weight, fat tissue distribution, and 
other recommended variables for measuring nutritional status.
Challenges in deriving global public health recommendations are 
unlikely to be resolved by ever-larger datasets without further 
developments in study data and design. New study designs such 
as Mendelian randomization (20), new data elements such as 
weight histories (21), and increased attention to BMI over the life 
course (22), might improve our understanding of BMI validity in 
measuring nutritional status at population level.
Finding a valid instrument to measure the nutritional status will 
continue to be a critical issue because of the implications in terms 
of health and economical resources for health care. This article 
contributes with a new piece of knowledge, but the discussion is 
still open. 
Important challenges remain in the effort to translate 
epidemiological evidence of excess bodyweight and obese 
information into effective guidelines and public health 
interventions. The Lancet, via the World Obesity Federation, 
and other coalitions such as the US National Collaborative on 
Childhood Obesity Research are championing diverse approaches 
to this challenge including support for better measurement, 
systems models, and increased attention to the evaluation of 
obesity-related policies (23). Substantial research and conceptual 
questions remain unsolved for these issues.
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